Home/Axxin/Andrew Lysikatos
AL

Andrew Lysikatos

Chief Executive Officer (CEO)

Axxin

Axxin Pipeline

DrugIndicationPhase
Melt Curve Analysis for Isothermal AmplificationPlatform enhancement for LAMP/Isothermal assaysDevelopment
Migration of Luminex Assays to Point-of-CareMultiplex assay transfer to Array Lateral Flow cartridgesCollaborative Development